L. Nagl

Rare lung cancers—Primary pulmonary leiomyosarcoma: A case report

G. Widmann, A. Pircher, K. Schmitz, 2021, memo - Magazine of European Medical Oncology.

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Mark S. Anderson, Chun Jimmie Ye, Gabriela K. Fragiadakis, 2022, Science immunology.

Fatigue at baseline is associated with geriatric impairments and represents an adverse prognostic factor in older patients with a hematological malignancy

R. Stauder, B. Borjan, K. Koinig, 2018, Annals of Hematology.

Molecular profiling in lung cancer

A. Pircher, G. Pall, L. Horvath, 2022, memo - Magazine of European Medical Oncology.

Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment – New Findings and Future Perspectives

A. Pircher, D. Wolf, L. Horvath, 2020, Frontiers in Cell and Developmental Biology.

Comorbidities cluster with impaired functional capacities and depressive mood and predict adverse outcome in older patients with hematological malignancies

R. Stauder, K. Koinig, L. Nagl, 2020, Leukemia & lymphoma.

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Mark S. Anderson, Chun Jimmie Ye, P. Gregersen, 2022, Science Immunology.